Glaxo seeks buyers for older products worth up to $12.6B

Carly Helfand GlaxoSmithKline has already made some moves to sell off some of its older meds. But now, it's making more that could end up much, much bigger. FiercePharma News
© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS